First outbreak of KPC-3-producing Klebsiella pneumoniae (ST258) clinical isolates in a Mexican Medical Center

Antimicrob Agents Chemother. 2013 Aug;57(8):4086-8. doi: 10.1128/AAC.02530-12. Epub 2013 Jun 3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / pharmacology
  • Bacterial Proteins / genetics
  • Bacterial Proteins / metabolism*
  • Ceftazidime / pharmacology
  • Cross Infection / epidemiology
  • Cross Infection / microbiology
  • Disease Outbreaks*
  • Drug Resistance, Multiple, Bacterial
  • Genes, Bacterial*
  • Health Personnel
  • Hospitals
  • Humans
  • Intensive Care Units
  • Klebsiella Infections / epidemiology*
  • Klebsiella pneumoniae / drug effects
  • Klebsiella pneumoniae / enzymology
  • Klebsiella pneumoniae / genetics
  • Klebsiella pneumoniae / isolation & purification*
  • Length of Stay
  • Mexico / epidemiology
  • Microbial Sensitivity Tests
  • Middle Aged
  • Risk Factors
  • Young Adult
  • beta-Lactamases / genetics
  • beta-Lactamases / metabolism*

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Ceftazidime
  • beta-Lactamases
  • beta-lactamase KPC-3, Klebsiella pneumoniae